title: Cholangiopathy associated with giardiasis in a patient with human immunodeficiency virus infection.
authors.forename: Marc J
authors.initials: MJ
authors.lastname: Zuckerman
authors.forename: Justus
authors.initials: J
authors.lastname: Peters
authors.forename: Rhonda V
authors.initials: RV
authors.lastname: Fleming
authors.forename: Darius
authors.initials: D
authors.lastname: Boman
authors.forename: Jesus E
authors.initials: JE
authors.lastname: Calleros
authors.forename: Douglas G
authors.initials: DG
authors.lastname: Adler
mesh_terms: D017088:AIDS-Related Opportunistic Infections / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology*; D000328:Adult; D000818:Animals; D000981:Antiprotozoal Agents / Q000627:therapeutic use; D001649:Bile Duct Diseases / Q000150:complications / Q000000981:diagnostic imaging*; D001653:Bile Ducts, Intrahepatic / Q000000981:diagnostic imaging / Q000469:parasitology; D002758:Cholangiography / Q000009:adverse effects*; D003135:Common Bile Duct / Q000000981:diagnostic imaging / Q000469:parasitology; D004108:Dilatation, Pathologic; D004866:Equipment Contamination; D005500:Follow-Up Studies; D016829:Giardia lamblia / Q000302:isolation & purification; D005873:Giardiasis / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology*; D006801:Humans; D008297:Male
chemical_list: D000981:Antiprotozoal Agents